Ad-hoc | 6 May 2002 07:31

Eckert & Ziegler AG english

Successful First Quarter for Eckert & Ziegler Ad-hoc-announcement transmitted by DGAP. The issuer is solely responsible for the content of this announcement. ——————————————————————————– Successful First Quarter for Eckert & Ziegler Berlin, 06.05.2002. According to preliminary calculations, Eckert & Ziegler, a Berlin-based specialist for low-level radioactive components, finished the first quarter of 2002 with revenues of 8.1 mm EUR and earnings before taxes of 1.1 mm EUR. The numbers represent an increase against last year’s first quarter of about 13% in revenues and 32% in earnings. Strongest growth was registered in the cardio-vascular and oncological product areas, which increased by 118% and 21%, respectively. The extraordinary expenses for the development of new therapeutic products against cancer at NEMOD Immuntherapie AG are not yet included in the above earnings. They will be published in the quarterly report on 28th May. The Board of Directors For further information please contact: Karolin Riehle Investor Relations Eckert & Ziegler AG Robert-Rössle-Str. 10 D – 13125 Berlin http://www.ezag.com Tel.: +49 (0) 30 / 94 10 84-138 Fax.:+49 (0) 30 / 94 10 84-112 end of ad-hoc-announcement (c)DGAP 06.05.2002 ——————————————————————————– WKN: 565970; ISIN: DE0005659700; Index: Listed: Neuer Markt in Frankfurt; Freiverkehr in Berlin, Bremen, Düsseldorf, Hamburg, Hannover, München und Stuttgart 060731 Mai 02